Unicycive Therapeutics To Present At The Guggenheim 3Rd Annual Healthcare Innovation Conference
Unicycive Therapeutics (NASDAQ: UNCY) CEO Shalabh Gupta, M.D., to present at the Guggenheim 3rd Annual Healthcare Innovation Conference on November 10, 2026, at 2:30 PM ET.
Unicycive Therapeutics to participate in Guggenheim's Healthcare Innovation Conference, highlighting its investigational kidney disease therapies, including oxylanthanum carbonate and UNI-494.
Unicycive Therapeutics, Inc. (NASDAQ:UNCY)
MOUNTAIN VIEW, CA, UNITED STATES, November 4, 2026 /EINPresswire / -- Unicycive Therapeutics, Inc. (“Unicycive” or the“Company”) (Nasdaq: UNCY), a biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer, will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on Tuesday, November 10, 2026, at 2:30 p.m. ET.Unicycive Therapeutics, Inc. is a B2i Digital Featured Company. See the company's in-depth profile at:
A link to the live and archived webcast may be accessed on the Unicycive website under the Investors section: Events and Presentations.
About Unicycive Therapeutics
Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive's lead investigational treatment is oxylanthanum carbonate, a novel phosphate-binding agent for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive's second investigational treatment, UNI-494, is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information, please visit Unicycive and follow us on LinkedIn and X.
Investor Contact:
Kevin Gardner
LifeSci Advisors
...
Media Contact:
Unicycive Therapeutics
...
SOURCE: Unicycive Therapeutics, Inc.
To learn more about the B2i Digital Media Network, visit
Additional Contact:
David Shapiro
B2i Digital, Inc.
+1 212-579-4844
...
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X
Other
UNCY to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference on Tue, Nov 10, 2026
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
You just read:
Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference News Provided By B2i Digital, Inc. November 04, 2026, 21:28 GMT Share This Article Distribution channels: Banking, Finance & Investment Industry, Business & Economy, Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry, Science
EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment